BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18414700)

  • 21. [Transient expression of fusion protein with a chimeric HBsAg-HSP70 construct in HepG2 cells].
    Liang ZW; Lan YH; Ren H; Li YG; Cai DC
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):248-52. PubMed ID: 12223130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches.
    Alves Vianna CO; da Silva E Mouta Júnior S; da Glória Teixeira Martins M; Batoreu NM; Queiroz JL; Gomes SA; Magalhães de Andrade Góes AC; Garcia Armoa GR; Marques CH; Baroni de Moraes MT
    J Immunol Methods; 2006 Jun; 313(1-2):38-47. PubMed ID: 16753174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity.
    Hossain MG; Ueda K
    PLoS One; 2017; 12(1):e0167871. PubMed ID: 28045894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction of replication-deficient recombinant adenoviral vector carrying HBsAg and HSP70 chimeric gene and its expression in vitro].
    Lei CL; Huang CH; Yang Z; Tang XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):136-9. PubMed ID: 18574539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7.
    Tan GH; Yusoff K; Seow HF; Tan WS
    J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Structure and expression of human hepatitis B virus surface antigen].
    Kozlovskaia TM; Pumpen PP
    Mol Biol (Mosk); 1986; 20(4):884-901. PubMed ID: 2429171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis and expression of the DNA fragment coding the antigenic determinant of the surface antigen protein of hepatitis B virus].
    Smirnov VD; Sergienko OV; Skripkin EA; Dubichev AG; Lunin VG
    Bioorg Khim; 1983 Oct; 9(10):1388-94. PubMed ID: 6207838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
    Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
    J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of HBsAg by using various eukaryotic expression vectors].
    Gu B; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):98-100. PubMed ID: 10488419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
    Matsubara N; Kusano O; Sugamata Y; Itoh T; Mizuii M; Tanaka J; Yoshizawa H
    Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays.
    Verheyen J; Neumann-Fraune M; Berg T; Kaiser R; Obermeier M
    J Clin Virol; 2012 Jul; 54(3):279-81. PubMed ID: 22595307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production in yeast of hepatitis B surface antigen by R-DNA technology.
    De Wilde M; Cabezon T; Harford N; Rutgers T; Simoen E; Van Wijnendaele F
    Dev Biol Stand; 1985; 59():99-107. PubMed ID: 4007280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection.
    Scheiblauer H; Soboll H; Nick S
    J Med Virol; 2006; 78 Suppl 1():S66-70. PubMed ID: 16622881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of hepatitis B surface antigen in tobacco cell suspension cultures.
    Sunil Kumar GB; Ganapathi TR; Revathi CJ; Prasad KS; Bapat VA
    Protein Expr Purif; 2003 Nov; 32(1):10-7. PubMed ID: 14680934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biosynthesis of recombinant human hepatitis B M-HBsAg in silkworm larvae].
    Likhoradova OA; Bachurina EIu; Azimova ShS
    Mol Biol (Mosk); 2004; 38(4):717-22. PubMed ID: 15456144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative study to detect the HBsAg by the ELISA, RIA and PHA technics in patients with viral hepatitis].
    Mutlu G; Kumdali A
    Mikrobiyol Bul; 1984 Oct; 18(4):190-8. PubMed ID: 6392836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phage with high affinity for hepatitis B surface antigen for the detection of HBsAg.
    Lu X; Weiss P; Block T
    J Virol Methods; 2004 Jul; 119(1):51-4. PubMed ID: 15109821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and evaluation of the eukaryotic expression plasmid encoding two copies of somatostatin genes fused with hepatitis B surface antigen gene S.
    Liang A; Cao S; Han L; Yao Y; Moaeen-Ud-Din M; Yang L
    Vaccine; 2008 Jun; 26(23):2935-41. PubMed ID: 18455280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers].
    Wu X; Zhou C; Huang WJ; Qi ZB; Liang ZL; Li HM; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):915-8. PubMed ID: 19173858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
    Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
    Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.